CLINICAL_TRIALS
trial_result
· 2017-05-03
Clinical Trial Update: Stereotactic Body Radiotherapy (SBRT) for Spinal/Para-Spinal Metastases (Spine SBRT) [Phase 2]
Summary
Phase 2 trial evaluating stereotactic body radiotherapy for spinal and paraspinal metastases has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: University Health Network, Toronto | Conditions: Spinal Metastases | Phase 2 | Status: COMPLETED